358247113	358247113	CD	B-NP	O
|	|	NN	I-NP	O
CHMC	CHMC	NN	I-NP	O
|	|	NN	I-NP	O
84503929	84503929	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
2918518	2918518	CD	B-NP	O
|	|	CC	I-NP	O
7/7/2006	7/7/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
HEART	HEART	NNP	I-NP	I-protein
FAILURE	FAILURE	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Unsigned	Unsigned	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/18/2006	1/18/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Unsigned	Unsigned	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/28/2006	2/28/2006	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
MORRONE	MORRONE	NNP	B-NP	O
,	,	,	O	O
NEAL	NEAL	NNP	B-NP	O
LIONEL	LIONEL	NNP	I-NP	O
MD	MD	NNP	I-NP	O
DEATH	DEATH	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
DATE	DATE	NNP	I-NP	O
OF	OF	NNP	I-NP	O
DEATH	DEATH	NNP	I-NP	O
:	:	:	O	O
5/23/06	5/23/06	CD	B-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
Mr.	Mr.	NNP	B-NP	O
Zicherman	Zicherman	NNP	I-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
59-year-old	59-year-old	JJ	I-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
Dalewan	Dalewan	NNP	B-NP	O
on	on	IN	B-PP	O
7/25/06	7/25/06	CD	B-NP	O
from	from	IN	B-PP	O
an	an	DT	B-NP	O
outside	outside	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
deteriorating	deteriorate	VBG	I-NP	O
ischemic	ischemic	JJ	I-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
in	in	IN	B-PP	O
1996	1996	CD	B-NP	O
and	and	CC	O	O
subsequently	subsequently	RB	B-VP	O
had	have	VBD	I-VP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
bypass	bypass	IN	B-PP	O
grafting	graft	VBG	B-VP	O
also	also	RB	B-ADVP	O
in	in	IN	B-PP	O
1996	1996	CD	B-NP	O
with	with	IN	B-PP	O
subsequent	subsequent	JJ	B-NP	O
occlusion	occlusion	NN	I-NP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
grafts	graft	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
four	four	CD	B-NP	O
previous	previous	JJ	I-NP	O
stents	stent	NNS	I-NP	O
in	in	IN	B-PP	O
native	native	JJ	B-NP	O
vessels	vessel	NNS	I-NP	O
,	,	,	O	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
biventricular	biventricular	JJ	I-NP	O
ICD	ICD	NN	I-NP	O
placed	place	VBN	B-VP	O
in	in	IN	B-PP	O
2000	2000	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
he	he	PRP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
and	and	CC	I-NP	O
hyperlipidemia	hyperlipidemia	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
increasing	increase	VBG	B-NP	O
signs	sign	NNS	I-NP	O
and	and	CC	I-NP	O
symptoms	symptom	NNS	I-NP	O
of	of	IN	B-PP	O
heart	heart	NN	B-NP	O
failure	failure	NN	I-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
gone	go	VBN	I-VP	O
from	from	IN	B-PP	O
class	class	NN	B-NP	O
I	I	CD	I-NP	O
failure	failure	NN	I-NP	O
to	to	TO	B-PP	O
class	class	NN	B-NP	O
IV	IV	CD	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
18	18	CD	I-NP	O
months	month	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
BNP	BNP	NN	I-NP	B-protein
of	of	IN	B-PP	O
1600	1600	CD	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
being	be	VBG	I-VP	O
treated	treat	VBN	I-VP	O
for	for	IN	B-PP	O
pneumonia	pneumonia	NN	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
evaluated	evaluate	VBN	I-VP	O
for	for	IN	B-PP	O
heart	heart	NN	B-NP	O
transplantation	transplantation	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
due	due	RB	B-ADVP	O
to	to	TO	B-PP	O
clinical	clinical	JJ	B-NP	O
deterioration	deterioration	NN	I-NP	O
was	be	VBD	B-VP	O
considered	consider	VBN	I-VP	O
for	for	IN	B-PP	O
ventricular	ventricular	JJ	B-NP	O
assist	assist	NN	I-NP	O
device	device	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
required	require	VBD	B-VP	O
inotropic	inotropic	JJ	B-NP	O
support	support	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
surgery	surgery	NN	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
other	other	JJ	I-NP	O
surgical	surgical	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
note	note	NN	B-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
As	As	IN	B-SBAR	O
mentioned	mention	VBN	B-VP	O
,	,	,	O	O
also	also	RB	B-ADVP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
mild	mild	JJ	B-NP	O
polycythemia	polycythemia	NN	I-NP	O
and	and	CC	I-NP	O
thrombocytopenia	thrombocytopenia	NN	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
/	/	SYM	I-NP	O
SOCIAL	SOCIAL	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Both	Both	DT	B-NP	O
parents	parent	NNS	I-NP	O
had	have	VBD	B-VP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
bypass	bypass	NN	I-NP	O
grafts	graft	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
80-pack-year	80-pack-year	JJ	I-NP	O
cigarette	cigarette	NN	I-NP	O
smoking	smoking	NN	I-NP	O
history	history	NN	I-NP	O
.	.	.	O	O

DRUG	DRUG	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
assessment	assessment	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
receiving	receive	VBG	I-VP	O
amiodarone	amiodarone	NN	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
digoxin	digoxin	NN	B-NP	O
0.125	0.125	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
heparin	heparin	NN	B-NP	O
continuous	continuous	JJ	I-NP	O
infusion	infusion	NN	I-NP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
continuous	continuous	JJ	I-NP	O
infusion	infusion	NN	I-NP	O
,	,	,	O	O
dobutamine	dobutamine	NN	B-NP	O
continuous	continuous	JJ	I-NP	O
infusion	infusion	NN	I-NP	O
,	,	,	O	O
milrinone	milrinone	NN	B-NP	O
continuous	continuous	JJ	I-NP	O
infusion	infusion	NN	I-NP	O
,	,	,	O	O
spironolactone	spironolactone	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Examination	Examination	NN	B-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
midline	midline	NN	I-NP	O
sternotomy	sternotomy	NN	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
crackles	crackle	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
and	and	CC	O	O
a	a	DT	B-NP	O
pansystolic	pansystolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
6/16/06	6/16/06	CD	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
complete	complete	JJ	B-NP	O
occlusion	occlusion	NN	I-NP	O
of	of	IN	B-PP	O
OM2	OM2	NN	B-NP	B-protein
,	,	,	O	O
proximal	proximal	JJ	B-NP	O
RCA	RCA	NN	I-NP	O
,	,	,	O	O
proximal	proximal	JJ	B-NP	O
LAD	LAD	NN	I-NP	O
,	,	,	O	O
90	90	CD	B-NP	O
%	%	NN	I-NP	O
occlusion	occlusion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
D1	D1	NN	I-NP	O
,	,	,	O	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
occlusion	occlusion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ramus	ramus	NN	I-NP	O
,	,	,	O	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
occlusion	occlusion	NN	I-NP	O
of	of	IN	B-PP	O
OM1	OM1	NN	B-NP	B-protein
.	.	.	O	O

His	His	PRP$	B-NP	O
LIMA	LIMA	NN	I-NP	O
to	to	TO	B-PP	O
LAD	LAD	NN	B-NP	O
graft	graft	NN	I-NP	O
was	be	VBD	B-VP	O
patent	patent	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
complete	complete	JJ	I-NP	O
occlusion	occlusion	NN	I-NP	O
of	of	IN	B-PP	O
vein	vein	NN	B-NP	O
graft	graft	NN	I-NP	O
to	to	TO	B-PP	O
RCA	RCA	NN	B-NP	B-protein
,	,	,	O	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
occlusion	occlusion	NN	I-NP	O
of	of	IN	B-PP	O
vein	vein	NN	B-NP	O
graft	graft	NN	I-NP	O
to	to	TO	B-PP	O
D2	D2	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
pulmonary	pulmonary	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O
with	with	IN	B-PP	O
mean	mean	JJ	B-NP	O
PA	PA	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
48	48	CD	B-NP	O
mmHg	mmHg	NN	I-NP	O
and	and	CC	O	O
pulmonary	pulmonary	JJ	B-NP	O
capillary	capillary	JJ	I-NP	O
wedge	wedge	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
33	33	CD	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	O
output	output	NN	I-NP	O
was	be	VBD	B-VP	O
3.5	3.5	CD	B-NP	O
liters	liter	NNS	I-NP	O
on	on	IN	B-PP	O
dobutamine	dobutamine	NN	B-NP	O
and	and	CC	I-NP	O
milrinone	milrinone	NN	I-NP	O
infusions	infusion	NNS	I-NP	O
.	.	.	O	O

Echocardiogram	Echocardiogram	NN	B-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
15	15	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
trivial	trivial	JJ	B-NP	O
AI	AI	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
MR	MR	NN	I-NP	B-protein
,	,	,	O	O
moderate	moderate	JJ	B-NP	O
TR	TR	NN	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
revealed	reveal	VBD	B-VP	O
atrial	atrial	JJ	B-NP	O
flutter	flutter	NN	I-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
104	104	CD	B-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
was	be	VBD	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
11/22/06	11/22/06	CD	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
reoperative	reoperative	JJ	B-NP	O
insertion	insertion	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
HeartMate	HeartMate	NNP	I-NP	O
left	leave	VBD	B-VP	O
ventricular	ventricular	JJ	B-NP	O
assist	assist	NN	I-NP	O
device	device	NN	I-NP	O
and	and	CC	O	O
tricuspid	tricuspid	JJ	B-NP	O
valvuloplasty	valvuloplasty	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
tolerate	tolerate	VB	I-VP	O
chest	chest	NN	B-NP	O
closure	closure	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
procedure	procedure	NN	B-NP	O
as	as	IN	B-PP	O
his	his	PRP$	B-NP	O
central	central	JJ	I-NP	O
venous	venous	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
high	high	JJ	B-ADJP	O
.	.	.	O	O

Postoperatively	Postoperatively	RB	B-ADVP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
coagulopathic	coagulopathic	JJ	B-ADJP	O
and	and	CC	O	O
inotrope	inotrope	NN	B-NP	O
and	and	CC	O	O
nitric	nitric	JJ	B-NP	O
oxide	oxide	NN	I-NP	O
dependant	dependant	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
2	2	CD	I-NP	O
,	,	,	O	O
some	some	DT	B-NP	O
progress	progress	NN	I-NP	O
was	be	VBD	B-VP	O
made	make	VBN	I-VP	O
weaning	wean	VBG	B-VP	O
inotropes	inotrope	NNS	B-NP	O
and	and	CC	B-PP	O
on	on	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
3	3	CD	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
chest	chest	NN	I-NP	O
closure	closure	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
pericardial	pericardial	JJ	I-NP	O
patch	patch	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
underwent	undergo	VBD	B-VP	O
exploratory	exploratory	JJ	B-NP	O
laparotomy	laparotomy	NN	I-NP	O
and	and	CC	O	O
sustained	sustain	VBD	B-VP	O
a	a	DT	B-NP	O
VT	VT	NN	I-NP	O
arrest	arrest	NN	I-NP	O
requiring	require	VBG	B-VP	O
discontinuation	discontinuation	NN	B-NP	O
of	of	IN	B-PP	O
cardioversion	cardioversion	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
require	require	VB	I-VP	O
nitric	nitric	JJ	B-NP	O
oxide	oxide	NN	I-NP	O
in	in	IN	B-PP	O
view	view	NN	B-NP	O
of	of	IN	B-PP	O
high	high	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
vascular	vascular	JJ	I-NP	O
resistance	resistance	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
6/13/06	6/13/06	CD	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
further	further	JJ	I-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
ventricular	ventricular	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
multiple	multiple	JJ	B-NP	O
electrical	electrical	JJ	I-NP	O
cardioversions	cardioversion	NNS	I-NP	O
and	and	CC	O	O
required	require	VBD	B-VP	O
amiodarone	amiodarone	NN	B-NP	O
and	and	CC	I-NP	O
epinephrine	epinephrine	NN	I-NP	O
.	.	.	O	O

Eventually	Eventually	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
converted	convert	VBD	B-VP	O
to	to	TO	B-PP	O
AV	AV	NN	B-NP	O
paced	paced	JJ	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
required	require	VBD	B-VP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
require	require	VB	I-VP	O
significant	significant	JJ	B-NP	O
inotropic	inotropic	JJ	I-NP	O
support	support	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
subsequently	subsequently	RB	B-ADVP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
multiple	multiple	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
ventricular	ventricular	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
converted	convert	VBN	I-VP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
AICD	AICD	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
this	this	DT	B-NP	O
stage	stage	NN	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	B-DNA
ongoing	ongoe	VBG	I-NP	O
hemodynamic	hemodynamic	JJ	I-NP	O
instability	instability	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
paralysed	paralyse	VBN	I-VP	O
with	with	IN	B-PP	O
Nimbex	Nimbex	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
nitric	nitric	JJ	I-NP	O
oxide	oxide	NN	I-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
for	for	IN	B-PP	O
ongoing	ongoe	VBG	B-VP	O
pulmonary	pulmonary	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
hemodynamically	hemodynamically	RB	B-ADJP	O
ustable	ustable	JJ	I-ADJP	O
.	.	.	O	O

On	On	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
5	5	CD	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
developed	develop	VBD	B-VP	O
cool	cool	JJ	B-NP	O
and	and	CC	I-NP	O
dusky	dusky	JJ	I-NP	O
extremities	extremity	NNS	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
bivalirudin	bivalirudin	NN	B-NP	O
although	although	IN	B-SBAR	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
stage	stage	NN	I-NP	O
his	his	PRP$	B-NP	O
HIT	HIT	NN	I-NP	O
screen	screen	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
became	become	VBD	B-VP	O
febrile	febrile	JJ	B-ADJP	O
with	with	IN	B-PP	O
temperatures	temperature	NNS	B-NP	O
to	to	TO	B-PP	O
103	103	CD	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
days	day	NNS	I-NP	O
#	#	#	B-NP	O
6	6	CD	I-NP	O
,	,	,	I-NP	O
7	7	CD	I-NP	O
and	and	CC	I-NP	O
8	8	CD	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
PA	PA	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
slowly	slowly	RB	B-ADVP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
improve	improve	VB	I-VP	O
and	and	CC	O	O
some	some	DT	B-NP	O
slow	slow	JJ	I-NP	O
progress	progress	NN	I-NP	O
was	be	VBD	B-VP	O
made	make	VBN	I-VP	O
weaning	wean	VBG	I-VP	O
his	his	PRP$	B-NP	O
epinephrine	epinephrine	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
this	this	DT	B-NP	O
stage	stage	NN	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
bilirubin	bilirubin	NN	I-NP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
increase	increase	VB	I-VP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
developed	develop	VBD	B-VP	O
some	some	DT	B-NP	O
melanotic	melanotic	JJ	I-NP	O
stool	stool	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
developed	develop	VBD	B-VP	O
renal	renal	JJ	B-NP	O
failure	failure	NN	I-NP	O
and	and	CC	B-PP	O
by	by	IN	B-PP	O
this	this	DT	B-NP	O
stage	stage	NN	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
increased	increase	VBD	B-VP	O
to	to	TO	B-PP	O
2.9	2.9	CD	B-NP	O
.	.	.	O	O

By	By	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
9	9	CD	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
Nimbex	Nimbex	NN	I-NP	O
and	and	CC	I-NP	O
fentanyl	fentanyl	NN	I-NP	O
infusions	infusion	NNS	I-NP	O
were	be	VBD	B-VP	O
stopped	stop	VBN	I-VP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
PA	PA	NN	I-NP	O
mean	mean	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
had	have	VBD	B-VP	O
reduced	reduce	VBN	I-VP	O
to	to	TO	B-PP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
30	30	CD	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
became	become	VBD	B-VP	O
febrile	febrile	JJ	B-NP	O
fevers	fever	NNS	I-NP	O
and	and	CC	O	O
developed	develop	VBD	B-VP	O
some	some	DT	B-NP	O
purulent	purulent	JJ	I-NP	O
discharge	discharge	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
VAD	VAD	NN	I-NP	O
driveline	driveline	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
12	12	CD	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
fluoroscopic	fluoroscopic	JJ	B-NP	O
placement	placement	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
post-pyloric	post-pyloric	JJ	I-NP	O
feeding	feeding	NN	I-NP	O
tube	tube	NN	I-NP	O
and	and	CC	O	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
spike	spike	VB	I-VP	O
temperatures	temperature	NNS	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
bilirubin	bilirubin	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
rise	rise	VB	I-VP	O
,	,	,	O	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
ammonia	ammonia	NN	I-NP	O
level	level	NN	I-NP	O
had	have	VBD	B-VP	O
also	also	RB	I-VP	O
risen	rise	VBN	I-VP	O
.	.	.	O	O

On	On	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
14	14	CD	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
unstable	unstable	JJ	B-ADJP	O
with	with	IN	B-PP	O
deteriorating	deteriorate	VBG	B-VP	O
liver	liver	NN	B-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
ongoing	ongoe	VBG	B-VP	O
renal	renal	JJ	B-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
metabolic	metabolic	JJ	B-NP	O
acidosis	acidosis	NN	I-NP	O
,	,	,	O	O
ongoing	ongoing	JJ	B-NP	O
fevers	fever	NNS	I-NP	O
,	,	,	O	O
hemodynamically	hemodynamically	RB	B-NP	O
instability	instability	NN	I-NP	O
and	and	CC	I-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
ventricular	ventricular	JJ	B-NP	O
tachycardia	tachycardia	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
by	by	IN	B-PP	O
this	this	DT	B-NP	O
stage	stage	NN	I-NP	O
developed	develop	VBD	B-VP	O
irreversible	irreversible	JJ	B-NP	O
loss	loss	NN	I-NP	O
of	of	IN	B-PP	O
fingers	finger	NNS	B-NP	O
and	and	CC	I-NP	O
toes	toe	NNS	I-NP	O
.	.	.	O	O

Due	Due	JJ	B-PP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	B-DNA
unrelenting	unrelente	VBG	B-VP	O
and	and	CC	I-VP	O
deteriorating	deteriorate	VBG	I-VP	O
multisystem	multisystem	JJ	B-NP	O
organ	organ	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
family	family	NN	I-NP	O
meeting	meeting	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
at	at	IN	B-PP	O
which	which	WDT	B-NP	O
the	the	DT	B-NP	O
poor	poor	JJ	I-NP	O
prognosis	prognosis	NN	I-NP	O
was	be	VBD	B-VP	O
discussed	discuss	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
family	family	NN	I-NP	O
elected	elect	VBD	B-VP	O
to	to	TO	I-VP	O
withdraw	withdraw	VB	I-VP	O
all	all	DT	B-NP	O
support	support	NN	I-NP	O
and	and	CC	O	O
on	on	IN	B-PP	O
5/23/06	5/23/06	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
AICD	AICD	NN	I-NP	O
was	be	VBD	B-VP	O
switched	switch	VBN	I-VP	O
off	off	RP	B-PRT	O
as	as	IN	B-SBAR	O
was	be	VBD	B-VP	O
the	the	DT	B-NP	O
ventilator	ventilator	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
ventricular	ventricular	JJ	I-NP	O
assist	assist	NN	I-NP	O
device	device	NN	I-NP	O
and	and	CC	I-NP	O
comfort	comfort	NN	I-NP	O
measures	measure	NNS	I-NP	O
were	be	VBD	B-VP	O
instituted	institute	VBN	I-VP	O
.	.	.	O	O

Mr.	Mr.	NNP	B-NP	O
Desilvo	Desilvo	NNP	I-NP	O
died	die	VBD	B-VP	O
at	at	IN	B-PP	O
7	7	CD	B-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
p.m.	p.m.	NN	I-NP	O
on	on	IN	B-PP	O
5/23/06	5/23/06	CD	B-NP	O
from	from	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
organ	organ	NN	I-NP	O
failure	failure	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
complications	complication	NNS	B-NP	O
of	of	IN	B-PP	O
ischemic	ischemic	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
and	and	CC	I-NP	O
placement	placement	NN	I-NP	O
of	of	IN	B-PP	O
ventricular	ventricular	JJ	B-NP	O
assist	assist	NN	I-NP	O
device	device	NN	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
0-2100988	0-2100988	CD	B-NP	O
EMSSten	EMSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
MIRA	MIRA	NNP	B-NP	O
,	,	,	O	O
BUDDY	BUDDY	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
GATTSHALL	GATTSHALL	NN	B-NP	O
,	,	,	O	O
BENNETT	BENNETT	NNP	B-NP	O
CRISTOPHER	CRISTOPHER	NNP	I-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
8090452	8090452	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
6/10/06	6/10/06	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
6/10/06	6/10/06	CD	B-NP	O

